Elizabeth Hexner, MD, MSTR

Nichols C, Frey N, Gill S, Hexner E, Hirsh RL, Hossain NM, Loren A, Martin ME, McCurdy SR, Munshi P, Perry L, Smith J, Litzky L, Madabhushi S, Baumrin E, Ahya VN, Porter DL. Pulmonary Alveolar Proteinosis After Allogeneic Stem Cell Transplant in a Patient Undergoing Multiagent Chronic Graft-Versus-Host-Disease Treatment Including Axatilimab , Am J Hematol: 2026

Suzuki A, Zhao L, Thorsheim C, Weiderhold B, Yang C, Tutwiler V, Casu C, Myerson JW, Hexner EO, Mohandas N, Muzykantov VR, Litvinov RI, Nagaswami C, Risman RA, Ji P, Stalker TJ, Goldman AR, Tang HY, Speicher DW, Janmey PA, Rivella S, Tong W, Weisel JW, Svitkina TM, Abrams CS. Aberrant erythrocyte rigidity in JAK2(V617F) myeloproliferative neoplasms underlies concurrent thrombosis and hemorrhage , Sci Transl Med, 18: 2026,eadt0044

Gotlib, J., Reiter, A., Radia, D. H., Alvarez-Twose, I., Deininger, M. W., George, T. I., Panse, J. P., Mital, A., Pettit, K. M., Vannucchi, A. M., Platzbecker, U., Hermine, O., Elshoury, A., Livideanu, C., Mesa, R. A., Ustun, C., Triggiani, M., Dybedal, I., Jurcic, J. G., Zanotti, R., Oh, S. T., Yacoub, A., Hexner, E. O., Bose, P., Lee, S. G., Sperr, W. R., Griffiths, E. A., Butler, M., Lubke, J., Bidollari, I., Lin, H. M., Rylova, S. N., Dimitrijevic, S., Munoz-Gonzalez, J. I., DeAngelo, D. J. Efficacy and safety of avapritinib in advanced systemic mastocytosis: 4-year follow-up of the PATHFINDER study , Blood Adv, 10(10): 2026,3676-3689

Barber-Rotenberg, J. S., Haas, A. R., Aggarwal, C., O'Hara, M., Hexner, E., Pequignot, E., Dowd, E., Ndeupen, S., Thai, E., Chen, F., Oner, B. S., Czuczman, C., Gonzalez, V. E., Fraietta, J. A., Hwang, W. T., Chew, A., Jadlowsky, J. K., Marshall, A., Shea, K. M., Jiang, Y., Cosey, A., Ferthio, R., Levine, B. L., Plesa, G., Siegel, D. L., Young, R. M., Sheppard, N. C., Albelda, S. M., June, C. H., Tanyi, J. L. Phase 1 study of autologous T cells bearing fully human chimeric antigen receptors targeting mesothelin in mesothelin-expressing cancers , Mol Ther, 34(5): 2026,2653-2665

Xu, J., McCoy, M., Martinez, Z., Sussman, J. H., Gao, D., Vincent, T. L., Wang, H., Ma, C., Elghawy, O., Chen, G. M., Yang, A. G., Polonen, P., Natan, K., Shraim, R., Newman, H., Hofmann, T. J., Scoma, S., DiNofia, A. M., Hunger, S. P., Yang, J. J., Mullighan, C. G., Bernt, K. M., Hexner, E. O., Grupp, S. A., Watanabe, K., June, C. H., Tan, K., Teachey, D. T., Diorio, C. CCR4 expression defines a targetable subset of T-cell acute lymphoblastic leukemia , Blood Adv, 10(8): 2026,2676-2686

Chen, G. M., Jain, A., Gering, D. T., Satulovsky, J., Datta, S., Lai, P., Karar, J., Gonzalez, V. E., Alexander, K., Chew, A., Jadlowsky, J. K., Ruella, M., Paruzzo, L., Amses, K. R., Rech, A. J., Stadtmauer, E. A., Frey, N. V., Hexner, E. O., Porter, D. L., Cohen, A. D., Gill, S. I., Garfall, A. L., Schuster, S. J., Mo, K. C., Liang, S. I., Spasic, M., Levine, B. L., Siegel, D. L., Ramirez-Fernandez, A., Cabanski, C. R., Yang, E., Mackall, C. L., Bushman, F. D., Good, Z., John Wherry, E., June, C. H., Fraietta, J. A. Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancer , Nat Biomed Eng, 10(4): 2026,803-814

Louloudis, I. E., Chen, Y. B., Spyrou, N., Alousi, A., Katsivelos, N., Ayuk, F., Weber, D., Hogan, W. J., Etra, A. M., Qayed, M., Aguayo-Hiraldo, P., Akahoshi, Y., Malki, M. M. A., Bolanos-Meade, J., Chanswangphuwana, C., Diniz, M., Eder, M., Hexner, E., Kitko, C. L., Kraus, S., Merli, P., Olson, T., MacMillan, M. L., Pidala, J., Reshef, R., Schechter, T., Wolfl, M., Baez, J., Eng, G., Gleich, S., Young, R., Nakamura, R., Ferrara, J. L. M., Levine, J. E. Performance of Treatment Response Assessment at Day 7 by Baseline Acute Graft-versus-Host Disease Severity , Transplant Cell Ther, 32(1): 2026,63 e1-63 e11

Akahoshi Y, Katsivelos N, Louloudis IE, Weber D, Ayuk F, Hogan WJ, Chen YB, Etra AM, Aguayo-Hiraldo P, Chanswangphuwana C, Choe HK, Hexner EO, Kitko CL, Al Malki MM, Merli P, Olson TS, Qayed M, Vasova I, Wölfl M, Baez J, Eng G, Gleich S, Morales G, Spyrou N, Young R, Diniz M, Nakamura R, Levine JE, Ferrara JLM. Systemic steroid treatment of grade I acute GVHD increases steroid-refractory GVHD and NRM , Blood Immunol Cell Ther: 2026

Gerds AT, Gotlib J, Abdelmessieh P, Ali H, Castells M, Chernak BJ, Espinoza-Gutarra MR, Fein Revell R, Green S, Gundabolu K, Hexner E, Jain T, Jamieson CH, Khan I, Kuykendall AT, Madanat YF, Masarova L, McMahon B, Mohan SR, Nadiminti KV, Oh S, Palmer J, Patel AB, Patel AA, Podoltsev N, Rein L, Salit R, Sehl M, Talpaz M, Wadleigh M, Wall SA, Bergman MA, Hochstetler C. NCCN Guidelines® Insights: Myeloproliferative Neoplasms, Version 2.2026 , J Natl Compr Canc Netw: 2026

Salit RB, Hexner EO, Gagelmann N, Kröger N, McLornan DP, Jain T, Gupta V, Hobbs GS, Tamari R, Robin M, Scott B, Saber W Defining remission following hematopoietic cell transplant for myelofibrosis: an international expert panel consensus , Leukemia, 39(12): 2025,2862-2865